BIRC5 and renal cell carcinoma: Silibinin, a chemotherapeutic/chemopreventive compound isolated from the plant Silybum marianum (milk thistle), was shown to inhibit cell growth and induces apoptosis by downregulating survivin together with caspase activation and EGFR-ERK pathway inhibition in RCC [30].